FAM71E1 can influence the protein's activity through various intracellular signaling pathways and mechanisms. Forskolin, for instance, directly targets adenylyl cyclase, which catalyzes the transformation of ATP to cAMP. The surge in cAMP levels activates protein kinase A (PKA), a key enzyme that can phosphorylate FAM71E1, leading to its activation. Similarly, dibutyryl-cAMP, a synthetic analogue of cAMP that can easily penetrate cell membranes, elevates PKA activity within cells, further promoting the phosphorylation and activation of FAM71E1. Epinephrine also elevates cAMP levels by engaging adrenergic receptors, activating PKA and facilitating the phosphorylation process of FAM71E1. On the other hand, IBMX raises cAMP levels indirectly by inhibiting phosphodiesterases, enzymes responsible for cAMP breakdown, which also contributes to the activation of FAM71E1 via PKA-mediated phosphorylation.
Other mechanisms of action include the manipulation of cellular calcium levels and the inhibition of protein phosphatases. Ionomycin, by acting as a calcium ionophore, increases intracellular calcium concentrations that can activate calcium-dependent kinases, which in turn may phosphorylate and activate FAM71E1. Thapsigargin, by inhibiting the SERCA pump, disrupts calcium homeostasis in a similar way, potentially resulting in the activation of FAM71E1 through calcium-mediated signaling pathways. Okadaic acid and calyculin A, by inhibiting protein phosphatases PP1 and PP2A, lead to an accumulation of phosphorylated proteins, thereby maintaining FAM71E1 in an activated state. PMA acts through the activation of protein kinase C (PKC), which can phosphorylate FAM71E1, although this is dependent on the specific cellular context and the regulatory mechanisms in place. Lastly, Anisomycin, through the activation of stress-activated protein kinases, and Cyclosporin A, through the inhibition of calcineurin, alter phosphorylation dynamics in the cell, which can lead to the activation of FAM71E1. Each chemical, through its distinct molecular action, converges on the modification of FAM71E1 activity via phosphorylation, a post-translational modification that can regulate protein function.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $260.00 $350.00 $500.00 | 34 | |
Isobutylmethylxanthine (IBMX) is a non-selective inhibitor of phosphodiesterases, which increases cAMP levels by preventing its degradation. Higher cAMP levels may enhance activation of PKA, which can then activate FAM71E1 through phosphorylation. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
Phorbol 12-myristate 13-acetate (PMA) activates protein kinase C (PKC), which may phosphorylate and thus activate FAM71E1 as part of signal transduction processes. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Ionomycin is a calcium ionophore that increases intracellular calcium levels, potentially activating calcium-dependent protein kinases such as calmodulin-dependent kinase (CaMK), which could then phosphorylate and activate FAM71E1. | ||||||
(−)-Epinephrine | 51-43-4 | sc-205674 sc-205674A sc-205674B sc-205674C sc-205674D | 1 g 5 g 10 g 100 g 1 kg | $41.00 $104.00 $201.00 $1774.00 $16500.00 | ||
Epinephrine binds to adrenergic receptors, which activates G proteins and subsequently leads to the activation of adenylyl cyclase, increasing cAMP levels. The increase in cAMP can activate PKA, which might then phosphorylate and activate FAM71E1. | ||||||
Okadaic Acid | 78111-17-8 | sc-3513 sc-3513A sc-3513B | 25 µg 100 µg 1 mg | $291.00 $530.00 $1800.00 | 78 | |
Okadaic Acid is an inhibitor of protein phosphatases PP1 and PP2A, leading to increased phosphorylation of proteins due to decreased dephosphorylation activity. This can result in the enhanced phosphorylation and activation of FAM71E1 by kinases in the cell. | ||||||
Anisomycin | 22862-76-6 | sc-3524 sc-3524A | 5 mg 50 mg | $99.00 $259.00 | 36 | |
Anisomycin is a protein synthesis inhibitor that can activate stress-activated protein kinases like JNK (c-Jun N-terminal kinase), which may phosphorylate and activate FAM71E1 as part of a stress response. | ||||||
Calyculin A | 101932-71-2 | sc-24000 sc-24000A | 10 µg 100 µg | $163.00 $800.00 | 59 | |
Calyculin A, like Okadaic Acid, is an inhibitor of protein phosphatases, specifically PP1 and PP2A, which can result in the hyperphosphorylation of cellular proteins. This could lead to the activation of FAM71E1 by maintaining its phosphorylation state. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $136.00 $446.00 | 114 | |
Thapsigargin is a SERCA pump inhibitor that leads to the increase of cytosolic calcium levels, which could activate calcium-dependent kinases capable of phosphorylating and activating FAM71E1. | ||||||
Dibutyryl-cAMP | 16980-89-5 | sc-201567 sc-201567A sc-201567B sc-201567C | 20 mg 100 mg 500 mg 10 g | $47.00 $136.00 $492.00 $4552.00 | 74 | |
Dibutyryl-cAMP is a cell-permeable analog of cAMP that can activate PKA directly within cells. The activation of PKA can lead to the phosphorylation and subsequent activation of FAM71E1. | ||||||
Cyclosporin A | 59865-13-3 | sc-3503 sc-3503-CW sc-3503A sc-3503B sc-3503C sc-3503D | 100 mg 100 mg 500 mg 10 g 25 g 100 g | $63.00 $92.00 $250.00 $485.00 $1035.00 $2141.00 | 69 | |
Cyclosporin A is an immunosuppressant that binds to the cytosolic protein cyclophilin, leading to the inhibition of the phosphatase activity of calcineurin. This inhibition might result in increased phosphorylation and activation of proteins including FAM71E1 by other kinases in the cell due to reduced dephosphorylation. | ||||||